eHealthMe - FDA and Social Media, Personalized eHealthMe - FDA and Social Media, Personalized

FDA and Social Media, Personalized

Drugs A-Z       Conditions A-Z       Feature support groups

Review: Hydrea and Gleevec

This review analyzes the effectiveness and drug interactions between Hydrea and Gleevec. It is created by eHealthMe based on reports of 595 people who take the same drugs from FDA and social media, and is updated regularly.

Get connected: join a mobile support group for people who take Hydrea and Gleevec >>>

What are the drugs

Hydrea (latest outcomes from 2,879 users) has active ingredients of hydroxyurea. It is often used in polycythemia vera.

Gleevec (latest outcomes from 20,437 users) has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml).

On Oct, 28, 2014: 595 people who take Hydrea, Gleevec are studied

Hydrea, Gleevec outcomes

Drug combinations in study:
- Hydrea (hydroxyurea)
- Gleevec (imatinib mesylate)

Drug effectiveness over time :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Hydrea is effectiven/an/an/an/an/an/a100.00%
(1 of 1 people)
Gleevec is effectiven/an/a0.00%
(0 of 1 people)

Most common drug interactions over time * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
White Blood Cell Count DecreasedAnaemiaAnorexiaAnaemiaNeoplasm MalignantRenal Failure AcutePancytopeniaHaemoglobin Decreased
PyrexiaHaemoglobin DecreasedAngina PectorisRashBreast CancerSpinal OsteoarthritisPyrexia
AnaemiaFatigueMalignant Neoplasm ProgressionInterstitial Lung DiseaseDyspnoeaVomitingAnaemia
Platelet Count DecreasedDiarrhoeaConvulsionOxygen Saturation DecreasedAtrial FibrillationGastrointestinal HaemorrhageNeoplasm Malignant
ThrombocytopeniaWhite Blood Cell Count DecreasedLipase IncreasedGastric Antral Vascular EctasiaThrombocytopeniaPenis CarcinomaNausea
Interstitial Lung DiseaseHaematocrit DecreasedCoronary Artery OcclusionHaemoglobin DecreasedConstipationHaemorrhoidal HaemorrhageRash
Aspartate Aminotransferase IncreasedPlatelet Count DecreasedAscitesWhite Blood Cell Count DecreasedPruritusCardiac FailurePleural Effusion
Haemoglobin DecreasedOedema PeripheralHepatic IschaemiaRenal Failure ChronicAstheniaLeukocytosisWhite Blood Cell Count Increased
Blood Bilirubin IncreasedPancytopeniaHepatic Function AbnormalPleural EffusionFatigueBreast CancerWhite Blood Cell Count Decreased
DyspnoeaPlatelet Count IncreasedIschaemic HepatitisPericardial EffusionGene Mutation Identification Test PositiveNeoplasm MalignantChronic Myeloid Leukaemia

Drug effectiveness by gender :

Hydrea is effective100.00%
(1 of 1 people)
Gleevec is effective0.00%
(0 of 1 people)

Most common drug interactions by gender * :

Haemoglobin DecreasedHaemoglobin Decreased
White Blood Cell Count DecreasedNeoplasm Malignant
NauseaInterstitial Lung Disease
FatiguePleural Effusion
DyspnoeaDrug Ineffective
RashWhite Blood Cell Count Increased
Platelet Count DecreasedChronic Myeloid Leukaemia

Drug effectiveness by age :

Hydrea is effectiven/an/an/an/an/an/an/a100.00%
(1 of 1 people)
Gleevec is effectiven/an/an/an/an/an/an/a0.00%
(0 of 1 people)

Most common drug interactions by age * :

Drug Exposure During PregnancyChloromaDrug Exposure During PregnancyPleural EffusionFace OedemaPyrexiaNeoplasm MalignantHaemoglobin Decreased
Premature BabyPleural EffusionPremature LabourWhite Blood Cell Count IncreasedRetinal OedemaAspartate Aminotransferase IncreasedRashAnaemia
Normal NewbornPathological FractureWhite Blood Cell Count IncreasedDrug Exposure During PregnancyMacular OedemaBlood Lactate Dehydrogenase IncreasedAnaemiaWhite Blood Cell Count Decreased
OsteolysisPlacental DisorderPancytopeniaGeneralised OedemaAlanine Aminotransferase IncreasedInterstitial Lung DiseasePyrexia
PneumoniaDyspnoeaSplenomegalyVomitingHeadachePyrexiaPlatelet Count Decreased
PancytopeniaHaemothoraxMaternal Exposure During PregnancyOedema NosVomitingPain In ExtremityNeoplasm Malignant
Renal Failure AcuteRespiratory DistressNormal NewbornDeathNeoplasm MalignantDrug IneffectivePleural Effusion
Haemoglobin DecreasedLeukostasisDyspnoea NosVentricular TachycardiaWhite Blood Cell Count DecreasedRenal Failure ChronicRash
Dermatitis AllergicInduced LabourChronic Myeloid LeukaemiaAnasarcaDyspnoeaFatigueOedema Peripheral
SwellingAcute Lymphocytic LeukaemiaGastric HaemorrhageDrug Exposure During PregnancyPlatelet Count DecreasedThrombocytopeniaFatigue

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Hydrea and Gleevec?

Get connected! Join a related mobile support group:
- support group for people who take Hydrea and Gleevec
- support group for people who take Gleevec
- support group for people who take Hydrea

Can you answer these questions (what is this?):

More questions for: Gleevec, Hydrea

You may be interested at these reviews (what is this?):

  • Hydroxyurea and pomegranate juice
    sorry for my bad english. i am a retired physician, specialist in i.medicine & gastroenterology. have essencial thrombocythemia since year 2000. mild hypercholesterolemia once treated wiht symvastatin 20 mg/day. during a certain time i began to take 100 cc of pomegranate juice/3 times per week ...

More reviews for: Gleevec, Hydrea

Complete drug side effects:

On eHealthMe, Hydrea (hydroxyurea) is often used to treat polycythemia vera. Gleevec (imatinib mesylate) is often used to treat chronic myelogenous leukemia (cml). Find out below the conditions the drugs are used for, how effective they are, and any alternative drugs that you can use to treat those same conditions.

What is the drug used for and how effective is it:

Other drugs that are used to treat the same conditions:

Recent related drug studies:

More related studies for: Gleevec, Hydrea

Recent related drug comparison:

More related comparisons for: Gleevec, Hydrea

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

44 million health professionals and patients have studied on eHealthMe. Recent studies:

- Omeprazole for a 40-year old man who has Hyperacidity (22 minutes ago)

- Rituxan for a 57-year old woman who has Non-hodgkin's Lymphoma Recurrent (1 hour ago)

- Amoxicillin for a 37-year old woman who has Ear Infection (3 hours ago)


Recent mobile support groups

- Buspar and Acquired Bronchiectasis

- Involuntary Slow And Twisting Movements and Omeprazole

- Hyperacidity

- Omeprazole

- Efudex and Headache


Recent user comments

- "I have been experiencing some chest discomfort on and ... " (3 hours ago)

- "Anxiety-driven retching when forcd to perform/present ... " (3 hours ago)

- "Horrible pain all over can't sleep due to sore throat ... " (7 hours ago)


Recent searches

- Keratitis Viral
- Pain Tooth Or Teeth
- Type 2 Diabetes
- Stress And Anxiety
- Knee Joint Replacement


About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

© 2014 All rights reserved. Use of this site constitutes acceptance of's terms of service and privacy policy.